Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study-Reference-Cited by-同舟云学术

Dual IHC and FISH Testing for ALK Gene Rearrangement in Lung Adenocarcinomas in a Routine Practice: A French Study

Published:2012-02 Issue:2 Volume:7 Page:348-354
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

McLeer-Florin Anne,Moro-Sibilot Denis,Melis Adrien,Salameire Dimitri,Lefebvre Christine,Ceccaldi Françoise,de Fraipont Florence,Brambilla Elisabeth,Lantuejoul Sylvie

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

2. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain;Pao;PLoS Med,2005

3. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

5. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on lung adenocarcinoma: invasive size, grading and STAS;Histopathology;2023-10-23

2. Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study;American Journal of Clinical Pathology;2023-09-08

3. Molecular Pathology of Lung Tumors;Molecular Surgical Pathology;2023

4. Cancer Biomarkers: A Long and Tortuous Journey;Biomarkers of the Tumor Microenvironment;2022

5. Diagnosis of NUT Carcinoma Despite False-Negative Next-Generation Sequencing Results: A Case Report and Literature Review;OncoTargets and Therapy;2021-08